IMAS Largest ever study


27 countries have contributed to IMAS

27 countries across five continents have now taken part in the International Map of Axial Spondyloarthritis (IMAS) – the biggest ever survey of people living with axSpA.  IMAS collects information about the impact of axSpA on all areas of life and is now in its final stages.


So far, almost 4,500 people worldwide have responded to the survey.  In 2022, we will have a set of data that represents the experiences of people living with axSpA around the world.  IMAS gathers and shares data on how people with axial spondyloarthritis (axSpA) experience their disease physically, psychologically and socially.


We thank our members that have supported the IMAS survey; without you, it would not be possible to collect this vital information.



Learn more about IMAS

Other NEWS

ASIF Member Webinar Series

The potential to treat axSpA via the gut microbiome   Watch Dr …

Read More
ASAS Annual Meeting – Report

  ASAS Annual Meeting - Report Patient representatives from ASIF were invited …

Read More
ASIF Council Meeting, Copenhagen 29-31 May 2022

ASIF Council Meeting, Copenhagen 29-31 May 2022 We are delighted that …

Read More